Global Alpha Dumps 229,000 Shares: Market Move Explained
A major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
This brief overview contrasts lifecycle funds with target date funds, highlighting key distinctions to help you choose the right fund for retirement planning.
18,693 articlesA major fund sold almost 230k ANIP shares in Q1, triggering volatility in the pharma stock. This article breaks down ...
JPMorgan's JEPI ETF offers a compelling income stream through covered calls on a diversified 110-name portfolio. This...
A tech-led rally has spotlighted triple-leveraged ETFs, sparking debate on long-run viability. This piece explains ho...
What a pop culture moment can teach us about money. When Mick Jagger Responds John to a joke about ‘nice’ power, it d...
If you want growth without chasing the hottest trades, three brilliant growth stock etfs can form a durable core. Thi...
As rate landscapes shift in 2026, three dividend-focused ETFs provide a disciplined path to durable retirement income...
A big jump in ezcorp stock 130% has investors buzzing. This piece explains what happened, why an investor sold millio...
This guide compares two popular bond ETFs—Fidelity Bond ETF (FIGB) and IEI—focusing on yield, fees, and risk. Learn p...
Two 2x NVIDIA ETFs, NVDX and NVDL, aim to mirror double daily moves in NVIDIA. This report breaks down how daily comp...
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Start your week with smart, practical investing ideas. This 10-item Monday Reads digest breaks down market trends, po...
When markets wobble, income-focused investors flock to high-yield ETFs. This piece dives into why the JPMorgan Equity...